The importance of treating pediatric AIDS in the elimination agenda

August 27, 2013

Scott Kellerman and colleagues argue that the scope of the current HIV elimination agenda must be broadened in order to ensure access to care and treatment for all children living with HIV.

In 2011, despite the global initiative to eliminate mother-to-child transmission of HIV, 330,000 new pediatric infections were added worldwide to the existing pool of 3.4 million children living with the virus. Children are more vulnerable to HIV infection and have higher morbidity and mortality. Without treatment, half of those children infected will die before the age of 2 years, yet only one third of those eligible for treatment are currently receiving antiretroviral therapy.

The paper argues that current initiatives focus on interventions within the traditional prevention cascade which involve prevention of mother-to-child transmission. This focus is welcome but it is not enough. The scope of the elimination agenda must be broadened in order to ensure access to care and treatment for all children living with HIV. This expanded agenda must address challenges around reducing and ensuring access to appropriate HIV testing, care, and treatment for all affected children.

Explore further: HIV testing for children must be improved

More information: Kellerman SE, Sugandhi N (2013) Pediatric AIDS in the Elimination Agenda. PLoS Med 10(8):e1001503. DOI: 10.1371/journal.pmed.1001503

Related Stories

HIV testing for children must be improved

July 20, 2010

National HIV programs should recognize that HIV testing and counseling systems designed for adults do not meet the needs of children. Therefore, according to Scott Kellerman from Management Sciences for Health, Virginia, ...

Study details age disparities in HIV continuum of care

June 17, 2013

Age disparities exist in the continuum of care for patients with the human immunodeficiency virus (HIV) with people younger than 45 years less likely to be aware of their infection or to have a suppressed viral load, according ...

HIV answers raise new ethical questions

July 31, 2013

The Food and Drug Administration's approval last year of the drug Truvada for prevention of HIV infection was a milestone in the fight against HIV/AIDS, but experts are cautioning that it is only the beginning of new ethical ...

Recommended for you

Mutational tug of war over HIV's disease-inducing potential

August 23, 2016

A study from Emory AIDS researchers shows how the expected disease severity when someone is newly infected by HIV reflects a balance between the virus' invisibility to the host's immune system and its ability to reproduce.

Dormant copies of HIV mostly defective, new study shows

August 8, 2016

After fully sequencing the latent HIV "provirus" genomes from 19 people being treated for HIV, scientists at Johns Hopkins Medicine report that even in patients who start treatment very early, the only widely available method ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.